The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.

The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatiana Ntube Salley, Manish Mishra, Shuchita Tiwari, Ashok Jadhav, Joseph Fomusi Ndisang
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c166a91c05ff447c8376536f3176defd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c166a91c05ff447c8376536f3176defd
record_format dspace
spelling oai:doaj.org-article:c166a91c05ff447c8376536f3176defd2021-11-18T08:46:10ZThe heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.1932-620310.1371/journal.pone.0079270https://doaj.org/article/c166a91c05ff447c8376536f3176defd2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260182/?tool=EBIhttps://doaj.org/toc/1932-6203The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.Tatiana Ntube SalleyManish MishraShuchita TiwariAshok JadhavJoseph Fomusi NdisangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79270 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tatiana Ntube Salley
Manish Mishra
Shuchita Tiwari
Ashok Jadhav
Joseph Fomusi Ndisang
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
description The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.
format article
author Tatiana Ntube Salley
Manish Mishra
Shuchita Tiwari
Ashok Jadhav
Joseph Fomusi Ndisang
author_facet Tatiana Ntube Salley
Manish Mishra
Shuchita Tiwari
Ashok Jadhav
Joseph Fomusi Ndisang
author_sort Tatiana Ntube Salley
title The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_short The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_full The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_fullStr The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_full_unstemmed The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
title_sort heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/c166a91c05ff447c8376536f3176defd
work_keys_str_mv AT tatianantubesalley thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT manishmishra thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT shuchitatiwari thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT ashokjadhav thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT josephfomusindisang thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT tatianantubesalley hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT manishmishra hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT shuchitatiwari hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT ashokjadhav hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT josephfomusindisang hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
_version_ 1718421347411951616